[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2584405B1 - Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation - Google Patents

Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation

Info

Publication number
FR2584405B1
FR2584405B1 FR868609017A FR8609017A FR2584405B1 FR 2584405 B1 FR2584405 B1 FR 2584405B1 FR 868609017 A FR868609017 A FR 868609017A FR 8609017 A FR8609017 A FR 8609017A FR 2584405 B1 FR2584405 B1 FR 2584405B1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical composition
composition containing
furosemide
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR868609017A
Other languages
English (en)
Other versions
FR2584405A1 (fr
Inventor
Lester Chafetz
Jose Philip
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of FR2584405A1 publication Critical patent/FR2584405A1/fr
Application granted granted Critical
Publication of FR2584405B1 publication Critical patent/FR2584405B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
FR868609017A 1985-07-02 1986-06-23 Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation Expired FR2584405B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/751,763 US4663348A (en) 1985-07-02 1985-07-02 Furosemide salts and pharmaceutical preparations thereof

Publications (2)

Publication Number Publication Date
FR2584405A1 FR2584405A1 (fr) 1987-01-09
FR2584405B1 true FR2584405B1 (fr) 1989-02-24

Family

ID=25023379

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868609017A Expired FR2584405B1 (fr) 1985-07-02 1986-06-23 Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation

Country Status (14)

Country Link
US (1) US4663348A (fr)
JP (1) JPS625975A (fr)
AU (1) AU599034B2 (fr)
BE (1) BE904986A (fr)
CH (1) CH670448A5 (fr)
DE (1) DE3619665A1 (fr)
DK (1) DK312586A (fr)
FR (1) FR2584405B1 (fr)
GB (1) GB2189239B (fr)
IT (1) IT1191972B (fr)
LU (1) LU86484A1 (fr)
NL (1) NL8601519A (fr)
SE (1) SE8602917L (fr)
ZA (1) ZA864207B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920145A (en) * 1988-02-29 1990-04-24 Gaf Chemical Corporation Water-soluble complexes of water-insoluble pharmaceutical compounds and preparation thereof
IT1237115B (it) * 1989-10-24 1993-05-18 Sali della furosemide, procedimento per la loro preparazione e composizionni farmaceutiche che li contengono
AU654831B2 (en) * 1991-12-03 1994-11-24 Kokuyo Kabushiki Kaisha Filing device openable/closable on both sides
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
FI114538B (fi) * 2001-01-12 2004-11-15 Finnfeeds Finland Ltd Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
SG183243A1 (en) * 2010-02-10 2012-09-27 Kissei Pharmaceutical Salt of fused heterocyclic derivative and crystal thereof
CN105431145B (zh) * 2013-04-05 2019-12-10 Sc医药品有限公司 用于呋塞米的皮下施用的药物制剂
CA3123718A1 (fr) 2019-01-04 2020-07-09 Sq Innovation Ag Compositions pharmaceutiques de furosemide et leurs utilisations
EA202192129A1 (ru) 2019-01-31 2021-10-19 ЭсСиФАРМАСЬЮТИКАЛЗ ИНК. Концентрированные жидкие фармацевтические составы фуросемида и способы их введения

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3565920A (en) * 1966-12-29 1971-02-23 Ciba Geigy Corp 5-sulfamyl-anthranilic acids
DK138322B (da) * 1970-07-13 1978-08-14 Dumex Ltd As Fremgangsmåde til fremstilling af N-substituered antranilsyrederivater.
FR2210607A1 (en) * 1972-12-20 1974-07-12 Aries Robert 4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid prepn. - from furfural and 4-chloro-5-sulphamoyl anthranilic acid
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
LU74319A1 (fr) * 1976-02-09 1977-08-19
DE3025367A1 (de) * 1980-07-04 1982-01-28 Hoechst Ag, 6000 Frankfurt Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung

Also Published As

Publication number Publication date
US4663348A (en) 1987-05-05
NL8601519A (nl) 1987-02-02
AU5889086A (en) 1987-01-08
ZA864207B (en) 1987-02-25
LU86484A1 (fr) 1986-12-02
FR2584405A1 (fr) 1987-01-09
AU599034B2 (en) 1990-07-12
GB8615275D0 (en) 1986-07-30
SE8602917L (sv) 1987-01-03
GB2189239A (en) 1987-10-21
DK312586D0 (da) 1986-07-01
JPS625975A (ja) 1987-01-12
IT8648183A0 (it) 1986-06-25
DE3619665A1 (de) 1987-01-08
BE904986A (fr) 1986-12-24
CH670448A5 (fr) 1989-06-15
IT1191972B (it) 1988-03-31
SE8602917D0 (sv) 1986-07-01
GB2189239B (en) 1989-02-01
DK312586A (da) 1987-01-03

Similar Documents

Publication Publication Date Title
FR2569402B1 (fr) Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
FR2505835B1 (fr) Nouvelles 1,2-diaminocyclobutene-3,4-diones, leur procede de preparation et composition pharmaceutique les contenant
FR2602974B1 (fr) Composition pharmaceutique contenant de la nicotine ou ses derives
PT81310B (fr) Procede de preparation de derives de piperidine et de compositions pharmaceutiques les contenant
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
FR2510572B1 (fr) Nouvelles thiazolidinediones, leur procede de production et preparation pharmaceutique les contenant
FR2522324B1 (fr) Pyrrole-acetamides, leur procede de preparation et composition therapeutique les contenant
FR2584405B1 (fr) Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation
FR2567519B1 (fr) Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation
FR2605004B1 (fr) Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant
FR2581385B1 (fr) Derives de piperazine 1,4-disubstitues, composition pharmaceutique les contenant; leur procede d'obtention
FR2600061B1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
FR2582835B1 (fr) Derives de la quinoleine, leur procede de preparation et compositions pharmaceutiques les contenant
FR2601951B1 (fr) Nouvelles tetrahydrocarbazolones, composition pharmaceutique les contenant et leur procede de preparation
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2586681B1 (fr) Derives du methylene-dioxy-phenanthrene et du stilbene, procede pour leur preparation et medicaments les contenant
BE889990A (fr) Nouveaux composes cytostatiques, leur procede de preparation et composition pharmaceutique les contenant
BE890874A (fr) Derives de la pyrimidine, leur procede de preparation et les compositions pharmaceutiques les contenant
BE878836A (fr) Derives d'acide hydroxamique, leur procede de preparation et medicament les contenant
FR2551440B1 (fr) Aminocyclopentanes, leur procede de preparation et compositions pharmaceutiques les contenant
FR2517672B1 (fr) Thioalcanoyl-carnitines, procede pour leur preparation et composition pharmaceutique les contenant
PT77767A (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
FR2518092B1 (fr) Composes de trihydroxyvitamine d3, leur procede de preparation et composition pharmaceutique les renfermant
MA20706A1 (fr) Sels de 3-acylaminobenzisothiazol-5, 5-dioxydes, procede pour leur preparation et leur application dans la lutte anti-parasitaire

Legal Events

Date Code Title Description
ST Notification of lapse